Pacific Edge Ltd

PEB

Company Profile

  • Business description

    Pacific Edge Ltd is a NewZealand based company involved in developing and commercializing diagnostic and prognostic tools for the early detection and management of cancers. It manages and operates the laboratories used for the detection of bladder cancer. The company operates in two segments: Commercial, which includes sales, marketing, laboratory, and support operations to run the commercial businesses world wide; and Research, which is into research and development of diagnostic and prognostic products for human cancer. The commercial segment contributes to the majority of the revenue. Pacific Edge has a product in the marketplace called Cxbladder. Its geographical segments are the United States, New Zealand, and the Rest of the World.

  • Contact

    87 St David Street
    P.O. Box 56
    DunedinSTL9016
    NZL

    T: +64 35776733

    https://www.pacificedgedx.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Diagnostics & Research

    Fiscal Year End

    31 March 2026

    Employees

    34

Stocks News & Analysis

stocks

BlackRock earnings: Market gains and inflows drive AUM and revenue to record highs

We plan to raise our fair value estimate of BlackRock stock.
stocks

Our view of ANZ’s strategic plan

Trying to please customers and shareholders with a simpler and leaner bank.
stocks

Perplexing buyback from overvalued ASX share

Earnings continue to grow but investor expectations are too high.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,271.605.50-0.06%
CAC 407,919.6214.64-0.18%
DAX 4024,236.94150.99-0.62%
Dow JONES (US)46,270.46202.880.44%
FTSE 1009,452.779.900.10%
HKSE25,714.89273.541.08%
NASDAQ22,521.70172.91-0.76%
Nikkei 22547,261.31413.990.88%
NZX 50 Index13,311.7034.710.26%
S&P 5006,644.3110.41-0.16%
S&P/ASX 2008,964.304.40-0.05%
SSE Composite Index3,864.930.30-0.01%

Market Movers